Alto Neuroscience, Inc. - Common Stock, $0.0001 par value per share (ANRO)

Historical Holders from Q1 2024 to Q3 2025

Symbol
ANRO on NYSE
Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
32,553,745
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
16,755,091
Holdings value
$67,358,617
% of all portfolios
0%
Number of holders
74
Number of buys
26
Number of sells
-35
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Alto Neuroscience, Inc. - Common Stock, $0.0001 par value per share (ANRO)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Commodore Capital LP 9.8% $12,826,149 3,190,267 Commodore Capital LP 20 Oct 2025
ARMISTICE CAPITAL, LLC 7.05% $4,590,800 1,996,000 Armistice Capital, LLC 30 Jun 2025
PERCEPTIVE ADVISORS LLC 7.3% $7,718,845 1,989,393 Perceptive Advisors LLC 03 Oct 2025
Point72 Asset Management, L.P. 7% -20% $4,349,855 -$1,030,788 1,907,831 -19.2% Steven A. Cohen 31 Mar 2025
K2 HealthVentures Equity Trust LLC 5.6% $3,688,709 1,617,855 K2 HealthVentures Equity Trust LLC 13 Jan 2025
FMR LLC 4.7% $2,885,445 1,265,546 FMR LLC 31 Dec 2024
BlackRock, Inc. 2.1% $1,234,213 561,363 BlackRock, Inc. 30 Jun 2025

Institutional Holders of Alto Neuroscience, Inc. - Common Stock, $0.0001 par value per share (ANRO)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 16,755,091 $67,358,617 -$1,672,072 $4.02 74
2025 Q2 17,296,212 $38,050,471 -$7,942,231 $2.2 78
2025 Q1 20,845,367 $45,026,701 -$4,167,716 $2.16 83
2024 Q4 22,530,140 $95,292,066 -$45,543,045 $4.23 77
2024 Q3 22,939,574 $265,498,730 +$37,026,413 $11.44 75
2024 Q2 18,600,674 $198,841,035 +$25,849,471 $10.69 58
2024 Q1 15,971,812 $245,167,778 +$245,167,778 $15.35 52